Patents by Inventor Bert Behnke

Bert Behnke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for producing recombinant RNase A
    Publication number: 20090259035
    Abstract: The invention relates to a method for producing recombinant RNase A in E. coli. Said method is characterised in that it uses a DNA sequence, which codes for an RNase A of bovine origin and which is adapted to the codon usage in E. coli. The invention relates to nucleic acid molecules, which contain a nucleic acid sequence that has been adapted to the codon usage in E. coli and to recombinant nucleic acid molecules, which contain an nucleic acid molecule of this type and permit the expression of the recombinant RNase A in E. coli.
    Type: Application
    Filed: March 22, 2005
    Publication date: October 15, 2009
    Inventors: Frank Gindullis, Bert Behnke, Alexander Caliebe
  • Recombinant production of human histone 1 subtypes and their use for therapeutic purposes
    Publication number: 20030078204
    Abstract: The invention relates to recombinantly produced human histone-1 subtypes and to their use for therapeutic purposes.
    Type: Application
    Filed: July 12, 2002
    Publication date: April 24, 2003
    Inventors: Kai Pohlmeyer, Bert Behnke, Ralf Zabiensky geb. Wick, Gerd Mayer
  • Process for the preparation of anthracyclinones
    Patent number: 4613464
    Abstract: The present invention relates to a new process for the preparation of anthracyclinones of the formula ##STR1## in which R denotes C.sub.1 -C.sub.4 -alkyl, R.sub.1 denotes H or OH, and R.sub.2 and R.sub.3 are different and each represent H or OH, and R.sub.4 and R.sub.5 are different and each represent H or OH, starting from a compound of the formula ##STR2## in which R.sub.1 and R have the abovementioned meaning. The compounds of the formula I are valuable intermediates in the preparation of the corresponding glycosides having cytostatic efficacy.
    Type: Grant
    Filed: August 10, 1984
    Date of Patent: September 23, 1986
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Karsten Krohn, Bert Behnke